
Cerlapirdine
CAS No. 925448-93-7
Cerlapirdine( SAM531 | SAM-531 | SAM 531 | PF-05212365 | P -05212365 | WAY-262,531 )
Catalog No. M27966 CAS No. 925448-93-7
Cerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 160 | Get Quote |
![]() ![]() |
10MG | 260 | Get Quote |
![]() ![]() |
25MG | 515 | Get Quote |
![]() ![]() |
50MG | 740 | Get Quote |
![]() ![]() |
100MG | 1017 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCerlapirdine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.
-
DescriptionCerlapirdine is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine is already in clinical development for the treatment of cognitive disorders related to Alzheimer's disease and schizophrenia. It works by acting as a selective 5-HT6 receptor antagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsSAM531 | SAM-531 | SAM 531 | PF-05212365 | P -05212365 | WAY-262,531
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorhSmo|mSmo
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number925448-93-7
-
Formula Weight409.5
-
Molecular FormulaC22H23N3O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 41.67 mg/mL (101.76 mM)
-
SMILESCN(C)CCCOc1ccc2n[nH]c(c2c1)S(=O)(=O)c1cccc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lauressergues E, et al. Pharmacological evaluation of a series of smoothened antagonists in signaling pathways and after topical application in a depilated mouse model. Pharmacol Res Perspect. 2016 Mar 4;4(2):e00214.
molnova catalog



related products
-
BIMU 8
BIMU 8 is a selective agonist of 5-HT4 with EC50s of 18 nM, 77 nM, and 540 nM for wild-type 5HT4 receptor, T3.36A, and W6.48A mutant 5-HT4.
-
SB1317
SB1317 is a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3).
-
Pimethixene
Pimethixene is a highly potent 5-HT1A, 5-HT2A, 5-HT2B, 5-HT2C, histamine H1, dopamine D2 and D4.4 as well as muscarinic M1 and M2 receptors antagonist(pKis of 7.63, 10.22, 10.44, 8.42, 10.14, 8.19, 7.54, 8.61 and 9.38, respectively).